Biopure to seek EU nod for blood substitute
This article was originally published in Clinica
Biopure plans to apply in mid-2006 for European approval to market its blood substitute, Hemopure.
You may also be interested in...
Cosmetics Industry Awaits ‘Critical’ Safety Assessment Clarification Under China’s New Framework Reg
The China State Council’s January approval of an overarching Cosmetics Supervision and Administration Regulation promises to bring about long-awaited reforms. But draft regulations targeted for release in coming months will be key to the implementation of CSAR provisions, the Personal Care Products Council says.
Trulicity’s broad CV label awarded by the US FDA should aid overall uptake of the GLP-1 class, cushioning the direct impact on Novo Nordisk’s rival, Ozempic, analysts said.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”